Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other Non-Current Assets (2016 - 2025)

Assembly Biosciences has reported Other Non-Current Assets over the past 11 years, most recently at $312000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $312000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $312000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $312000.0, changed 0.0%.
  • Other Non-Current Assets for Q4 2025 was $312000.0 at Assembly Biosciences, roughly flat from $312000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for ASMB hit a ceiling of $6.1 million in Q2 2021 and a floor of $312000.0 in Q4 2023.
  • Median Other Non-Current Assets over the past 5 years was $333000.0 (2023), compared with a mean of $1.3 million.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 263.28% in 2021 and later crashed 84.64% in 2023.
  • Assembly Biosciences' Other Non-Current Assets stood at $1.7 million in 2021, then tumbled by 47.8% to $889000.0 in 2022, then plummeted by 64.9% to $312000.0 in 2023, then changed by 0.0% to $312000.0 in 2024, then changed by 0.0% to $312000.0 in 2025.
  • The last three reported values for Other Non-Current Assets were $312000.0 (Q4 2025), $312000.0 (Q3 2025), and $312000.0 (Q2 2025) per Business Quant data.